Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $300.0000 (-1.64%) ($300.0000 - $315.0000) on Fri. Nov. 11, 2011. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 5.29% (three month average) | | RSI | 66 | | Latest Price | $300.0000(-1.64%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | | Weekly Trend | CAPR advances 2.1% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
IWM(4%) PEJ(4%) EWP(3%) XAR(3%) XOP(3%) | | Factors Impacting CAPR price | CAPR will decline at least -2.645% in a week (0% probabilities).
REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -2.645% (StdDev 5.29%) | | Hourly BBV | 0 () | | Intraday Trend | -3.2% | | | | | |
|
| 5 Day Moving Average | $298(0.67%) | | 10 Day Moving Average | $298.18(0.61%) | | 20 Day Moving Average | $293.93(2.07%) | | To recent high | -17.8% | | To recent low | 20% | | Market Cap | $5.909b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |